-
Abstract Number: PO188
“Heparin Failure” in Seminoma-related Dramatic Hypercoagulable Melieu and Extended Vein Thrombosis: Is it BEP Protocol Ongoing Responsible?
-
Abstract Number: PB0016
“Red Cardiac versus White Atherosclerotic Thromboemboli in Acute Ischemic Stroke”: Challenging the Concept via a Large-scale, Detailed Multi-parametric Histological Analysis
-
Abstract Number: OC 28.4
Candida albicans Expresses an Integrin-like Protein that Promotes Endothelial Attachment and Vascular Leakage during Fungal Sepsis
-
Abstract Number: OC 30.3
CDKN2A Mutational Status is Associated with Venous Thromboembolism in Patients with Glioblastoma
-
Abstract Number: OC 32.1
Ex vivo Assessment of the Importance of Activated Factor IX (FIXa) Levels in the Procoagulant Effect of Recombinant FIX Concentrates in Emicizumab-treated Patients
-
Abstract Number: PB0057
Ex vivo Evaluation of the Effect of Plasma-derived Factor VIII/von Willebrand Factor in Patients with Severe Hemophilia A on Prophylaxis with Emicizumab by ROTEM
-
Abstract Number: PB0326
In silico Methods of Structural Biology for Studying (Not Only) Coagulation Proteins
-
Abstract Number: OC 75.3
In vitro and In vivo Models to Understand One-stage and Chromogenic Factor VIII Activity Assay Discrepancy of Hepatocyte-derived Factor VIII
-
Abstract Number: PB0375
In vitro Neutralization of Low Molecular Weight Heparins for the Measurement of Fibrin Polymerization Profile and Coagulation-fibrinolysis Balance
-
Abstract Number: OC 04.4
13C Metabolic Flux Analysis in Resting and Thrombin Activated Platelets
-
Abstract Number: PB0608
MOdern Treatment of Inhibitor-PositiVe PATiEnts with Haemophilia A – MOTIVATE (www.motivate-study.com)
-
Abstract Number: PB0627
PRactical Utilisation of Octapharma FVIII Concentrates in Previously Untreated and Minimally Treated Haemophilia A Patients Entering Routine Clinical Treatment with Nuwiq®, octanate® or wilate® – The Protect-NOW Study
-
Abstract Number: PB0594
2 Years ofPprophylaxis with rFVIII-Fc in Haemophilia in a Portuguese Haemophilia Center: Did Doctors and Patients See a Change?
-
Abstract Number: OC 64.2
25mmHg vs. 35mmHg Elastic Compression Stockings to Prevent Post Thrombotic Syndrome after Deep Vein Thrombosis: The CELEST Double-blind Trial
-
Abstract Number: OC 25.3
36-month Clinical Outcomes of Patients with Venous Thromboembolism: GARFIELD-VTE
-
Abstract Number: PB0653
52 Week Efficacy and Safety of Etranacogene Dezaparvovec in Adults with Severe or Moderate-severe Hemophilia B: Data from the Phase 3 HOPE-B Gene Therapy Trial
-
Abstract Number: PB1040
A 3D in vitro Model of Inflammation-associated Bleeding
-
Abstract Number: PB0784
A 5-Year Study of Arterial and Venous Thromboses in Greek Infants, Children and Adolescents. Comparison of Data Before and during the Pandemic Period
-
Abstract Number: PB0624
A Bleed Suppression Efficacy of Emicizumab in Patients with Hemophilia A whose Therapies Switched from Conventional Prophylaxis
-
Abstract Number: OC 48.1
A Blood Coagulation Factor IX Variant that Functions Independently of Factor VIII Mitigates the Hemophilia A Phenotype in Patient Plasma
- 1
- 2
- 3
- …
- 91
- Next Page »